|
Video: What is a Stock Split?
|
|
Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. Co.'s product portfolio are: ENROUTE Transcarotid Neuroprotection System, which is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, which is a self-expanding, self-tapering stent that conforms to patient; ENHANCE Transcarotid Peripheral Access Kit, which is used in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire, which is used for navigating and crossing the target lesion for delivery of interventional devices. According to our SILK split history records, Silk Road Medical has had 1 split. | |
|
Silk Road Medical (SILK) has 1 split in our SILK split history database. The split for SILK took place on February 05, 2001. This was a 1 for 70 reverse split, meaning for each 70 shares of SILK owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 14.2857142857143 share position following the split.
When a company such as Silk Road Medical conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SILK split history from start to finish, an original position size of 1000 shares would have turned into 14.2857142857143 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Silk Road Medical shares, starting with a $10,000 purchase of SILK, presented on a split-history-adjusted basis factoring in the complete SILK split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/05/2019 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$35.80 |
|
End price/share: |
$17.80 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-50.28% |
|
Average Annual Total Return: |
-12.89% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,972.37 |
|
Years: |
5.06 |
|
|
|
Date |
Ratio |
02/05/2001 | 1 for 70 |
|
|